Ozyerli-Goknar, E., Kala, E., Aksu, A., Bulut, I., Cingoz, A., Nizamuddin, S., Biniossek, M., Seker-Polat, F., Morova, T., Aztekin, C., Kung, S., Syed, H., Tuncbag, N., Gonen, M., Philpott, M., Cribbs, A., Acilan, C., Lack, N., Onder, T. & Timmers, H. (2023.0) Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. CELL COMMUNICATION AND SIGNALING , 21.0(1.0), 16.0.